FDA Should Call Last Round For OTC Hangover Indication, Cmte. Suggests
This article was originally published in The Pink Sheet
Executive Summary
Comments from the Nonprescription Drug and the Drug Safety and Risk Management advisory committees during a joint meeting could push US FDA toward pulling the plug on hangover as a monograph indication.